The pcDNA™ vectors are designed for high-level, constitutive expression in a variety of mammalian cell lines. The Gateway™ pcDNA™-DEST47 vector深入閱讀
Have Questions?
產品號碼 12281010
價格 (HKD)/ Each
價格5,318.00
您的價格登入登入以查看您的帳戶報價。需要一個帳戶嗎?今天就向我們註冊。
***
新增至購物車
價格 (HKD)/ Each
價格5,318.00
新增至購物車
Gateway™ pcDNA™-DEST47 Vector
產品號碼12281010
價格 (HKD)/ Each
價格5,318.00
-
新增至購物車
The pcDNA™ vectors are designed for high-level, constitutive expression in a variety of mammalian cell lines. The Gateway™ pcDNA™-DEST47 vector offers the following key features:
•C-terminal Cycle 3 GFP tag for rapid detection of recombinant protein •Cytomegalovirus (CMV) promoter for high-level expression •attR sites for Gateway™ cloning, enabling recombination with attL-flanked fragments •Neomycin resistance gene for stable selection •Ampicillin resistance gene and pUC origin for selection and maintenance in E. coli
Gateway™ Cloning To fit all of your expression needs, Invitrogen offers state-of-the-art Gateway™ destination vectors for expression in E. coli, insect, yeast, or mammalian cells, as well as for production of native protein or N- or C-terminal fusion proteins. All Gateway™ destination vectors have attR sites for recombination with any attL-flanked fragment, regardless of whether it is an entry clone or an Ultimate™ ORF Clone. The following table lists a variety of available destination vectors.
Additional materials required, available separately: Gateway™ entry clone, appropriate Gateway™ LR Clonase™ enzyme mix, and reaction buffer.
For Research Use Only. Not for use in diagnostic procedures.
規格
Constitutive or Inducible SystemConstitutive
Delivery TypeTransfection
PromoterCMV
Product TypeGateway System Destination Expression Vector
Reporter GeneGFP (Cycle 3)
Selection Agent (Eukaryotic)Geneticin™ (G-418)
Protein TagGFP (Cycle 3)
Cloning MethodGateway
Quantity6 μg
VectorpDEST, pcDNA
Product LineGateway™, pDEST™
For Use With (Application)Constitutive Expression
Unit SizeEach
內容物與存放
All destination vectors are provided lyophilized and supercoiled.